4884 · Kringle Pharma,Inc. · Financials
Market Cap
4.19B JPY
Shares
8.08M
Volume · Nov 12
317.6K
Avg daily vol (3M)
276.91K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
72.22M
-9.8%
FY2025
Net Income
-916.26M
-21.1%
FY2025
Gross Margin
100%
0pp
FY2025
Operating Margin
-1259.37%
-237.5pp
FY2025
Operating Cash Flow
-755.78M
-14.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 72.22M | 80.04M | 69.25M | 391.83M | 289.76M |
| JPY | 72.22M | 80.04M | 69.25M | 303.42M | 218.16M |
| JPY | -909.45M | -817.88M | -888.76M | -426.17M | -357.88M |
| JPY | -914.76M | -754.96M | -852.66M | -330.34M | -299.68M |
| JPY | 1.5M | 1.49M | 1.49M | 1.49M | 1.49M |
| JPY | -916.26M | -756.45M | -854.15M | -331.83M | -301.17M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.